|
Milk
Related Debates
The
genetically modified organism debate has largely ignored the
dairy industry’s two main biotech substances -- recombinant
bovine somatotropin and chymosin -- though efforts indicates
milk-related products aren’t immune from public discussion.
The
environmentalist group’s stance is echoed by such dairy companies
as Horizon Organic Dairy, Ben & Jerry’s Homemade Inc. and
Stonyfield Farm, which have made anti-GMO sentiments central
to their images. But to hear some food tech pundits tell it, the whole flap is much
ado about nothing.
“There
is absolutely no sane data indicating a problem with rBST (recombinant
bovine somatotropin),” said Robin Woo, director, Ceres Forum,
Georgetown University, Center for Food & Nutrition. “It’s
a wonderful tool, particularly in the Third World where they’re
trying to boost dairy output and increase calcium and protein
consumption in their populations. The
dairy industry was there at the beginning with biotech,” Woo
told dairy processors during IDFA’s recent Cultured Dairy Products
Conference in Las Vegas. “The world embraces chymosin because
you have taken it under your wing. Chymosin is still in England
even though they’re marching in the streets against biotech.”
The enzyme’s recombinant version currently is used in
80% to 90% of U.S.-manufactured cheese, according to C. Gordon
Brown, IDFA senior vice president, scientific and regulatory
affairs.
In
addition, rBST is used in one-third of U.S. dairy cows, but
because of pooling, one could argue that figure is considerably
higher, he indicated. “The
dairy industry has been a benefactor of biotechnology,” Brown
said during the conference. “Although we haven’t been on the
radar screen as some of these other bioengineered products have
been.” But other
nations aren’t as fond of the technology. To date, Canada and
the European Union nations prohibit rBST use in dairy cows.
In banning the hormone last year, Canadian authorities
stated that studies indicate it increases the risk of mastitis,
lameness and infertility in animals. A European Commission study
released in March 1999 indicated that rBST-treated milk contains
excess levels of insulin-like growth factor, which is linked
to human breast and prostate cancer.
Pressing
Matters
Dave Schmidt, Senior
Vice-President of food safety for the International Food Information
Council said he believes, as do others, that chymosin has escaped
scrutiny because some activists regard creating a recombinant
version as more humane than the traditional method of obtaining
the enzyme from calves’ stomachs.
IFIC
is a nonprofit organization whose self-described mission is
to communicate science-based information on food safety and
nutrition to health and nutrition professionals, educators,
government officials, journalists and others providing information
to consumers. “When we
look at how the media covers biotech, 70% of stories reported
on perceived harms,” Schmidt said during the cultured dairy
event. “That had something to do with fueling consumer attitudes
last summer. Some people
think philosophically there’s something wrong with biotech because
it’s outside Mother Nature,” he said. “We prefer to look at
biotech as an evolutionary phenomenon, that we’re building on
what came before. Don’t present it as an overnight phenomenon.”
Though
Horizon Organic Dairy, for example, has become the first-ever
national milk brand in the United States, Schmidt warned processors
against focusing the bulk of their efforts on organic methods
in making products. “I
think there’s an upper limit to how many people are going to
pay that additional price (for organic products),” he said.
“It’s going to come down to taste and price. Throwing all your
eggs in that basket, I think you’ll come up short based on supply
and demand.” However,
Horizon CEO Chuck Marcy predicted that GMO press coverage would
exert pressure on processors to “get rid of all those nasty
things in the milk supply.”
Schmidt
maintains that there are no safety issues regarding biotech
and that companies using the technology need to stand fast in
the face of what is often an emotional, not a scientific, debate.
“When
trusted food companies run from biotech, you can actually create
consumer concern with that simple act,” he said. “It becomes
a self-fulfilling prophecy.
“We can’t be put on the defensive with outrageous charges
without explaining why we pursued biotech in the first place,”
Schmidt said. “Biotech does have a link to traditional agriculture
and it’s just an extension. Some
claims have been so sensational. You need to be able to respond
with science.”
The above article was compiled
by Gerry Clark, Managing Editor for DairyNetwork.com.
|